Cybin Inc.
CYBN
Rank in Stocks
#13322
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission... Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
Share Price
$7.15
Last synced: 2026-11-17
Market Cap
$374.33M
Change (1 day)
-6.25%
Change (1 year)
26.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cybin Inc. (CYBN)
Category
Healthcare
Operating Margin for Cybin Inc. (CYBN)
Operating Margin as of November 2026 TTM: 0.00%
According to Cybin Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Cybin Inc. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -3,592.01% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 59.80% | - |
US
|
|
| 31.60% | - |
SE
|
|
| 30.13% | - |
FR
|
|
| 29.76% | - |
HK
|
|
| 31.11% | - |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cybin Inc.'s operating margin
What was Cybin Inc.'s operating margin in 2025?
In 2025, Cybin Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Cybin Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cybin Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2021 (-3,592.01%).
How does Cybin Inc.'s operating margin compare with similar companies?
Cybin Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.